Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

334
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
334

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Increased MASH-associated liver cancer in younger demographics.

Hepatology communications·2025
Same author

Mortality of Gastrointestinal Cancers Attributable to Smoking, Alcohol, and Metabolic Risk Factors, and its Association With Socioeconomic Development Status 2000-2021.

The American journal of medicine·2025
Same author

Alcohol-Related Liver Disease, Followed by Metabolic Dysfunction-Associated Steatotic Liver Disease, Emerges as the Fastest-Growing Aetiologies for Primary Liver Cancer in the United States.

Alimentary pharmacology & therapeutics·2025
Same author

Do Risk Factors for HCC Impact the Association of CT/MRI LIRADS Major Features With HCC? An Individual Participant Data Meta-Analysis.

Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes·2024
Same author

Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment.

Clinical and molecular hepatology·2024
Same author

Value of HCC surveillance in a landscape of emerging surveillance options: Perspectives of a multi-stakeholder modified Delphi panel.

Hepatology (Baltimore, Md.)·2024

Related Experiment Video

Updated: Jun 17, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

239

Comparing SEER and NCDB: a case study using colorectal cancer.

Po-Hong Liu1, Sandi L Pruitt2, Amit G Singal3

  • 1Division of Digestive and Liver Diseases, Department of Medicine, University of Texas Southwestern Medical Center, 5959 Harry Hines Blvd, Suite 520U, Dallas, TX, 75235, USA. stuartliu@gmail.com.

Cancer Causes & Control : CCC
|August 6, 2024
PubMed
Summary

Comparing cancer data from the Surveillance, Epidemiology, and End Results (SEER) Program and the National Cancer Database (NCDB) reveals distinct strengths. SEER offers detailed demographic and socioeconomic data, while NCDB excels in specific tumor and treatment information for cancer research.

Keywords:
Colorectal cancerEpidemiologyNCDBSEER

More Related Videos

Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

393
Clinical Application of Single-Surgeon, Three-Port, Laparoscopic Resection for Colorectal Cancer with Natural Orifice Specimen Extraction
08:26

Clinical Application of Single-Surgeon, Three-Port, Laparoscopic Resection for Colorectal Cancer with Natural Orifice Specimen Extraction

Published on: March 24, 2023

434

Related Experiment Videos

Last Updated: Jun 17, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

239
Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

393
Clinical Application of Single-Surgeon, Three-Port, Laparoscopic Resection for Colorectal Cancer with Natural Orifice Specimen Extraction
08:26

Clinical Application of Single-Surgeon, Three-Port, Laparoscopic Resection for Colorectal Cancer with Natural Orifice Specimen Extraction

Published on: March 24, 2023

434

Area of Science:

  • Oncology
  • Cancer Epidemiology
  • Health Services Research

Background:

  • Nationwide cancer registries like the Surveillance, Epidemiology, and End Results (SEER) Program and the National Cancer Database (NCDB) are crucial for cancer research in the U.S.
  • Understanding the unique strengths and limitations of SEER and NCDB is essential for robust study design and accurate interpretation of cancer trends and outcomes.
  • Colorectal cancer (CRC) serves as a valuable case study for comparing the data richness and coverage of these two major cancer databases.

Purpose of the Study:

  • To conduct a comparative analysis of the Surveillance, Epidemiology, and End Results (SEER) Program and the National Cancer Database (NCDB) using colorectal cancer (CRC) as a model.
  • To evaluate the differences in available demographic, clinical, treatment, and area-level data between SEER and NCDB for cancer research.
  • To inform researchers on the optimal selection of databases for specific cancer research questions.

Main Methods:

  • Utilized colorectal cancer (CRC) patient data from the Surveillance, Epidemiology, and End Results (SEER) Program (n=575,128) and the National Cancer Database (NCDB) (n=1,578,046) diagnosed between 2004 and 2021.
  • Compared key patient characteristics including age, tumor location, stage, and treatment distribution between the two datasets.
  • Assessed the availability of specific data elements such as racial/ethnic diversity, area-level socioeconomic factors, tumor molecular markers, and treatment details.

Main Results:

  • Demographic and clinical characteristics (age, tumor location, stage, treatment) were comparable between SEER and NCDB for colorectal cancer.
  • SEER captured a higher proportion of Hispanic and Asian/Pacific Islander individuals and included more area-level socioeconomic data.
  • NCDB provided more detailed tumor characteristics (e.g., microsatellite instability, KRAS mutation) and treatment outcomes (e.g., 30-day mortality, readmissions), while SEER uniquely offers age-adjusted incidence, mortality rates, and cause-specific survival.

Conclusions:

  • Both SEER and NCDB are valuable resources for cancer research, but they offer complementary data strengths.
  • SEER is advantageous for studies examining population-level disparities, socioeconomic factors, and incidence/mortality trends.
  • NCDB is better suited for research focused on treatment effectiveness, molecular characteristics, and detailed surgical outcomes.